Volume 7, Issue 1 (2022)
SJMR 2022, 7(1): 15-23 |
Back to browse issues page
Research code: 0
Ethics code: 0
Clinical trials code: 0
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nateghi M R, Sanaye Naderi M, Saremi A. Vertical transmission of Covid-19 disease through mother to neonate: A cross-sectional study. SJMR 2022; 7 (1) : 2
URL: http://saremjrm.com/article-1-252-en.html
URL: http://saremjrm.com/article-1-252-en.html
1- Sarem gynecology, Obstetrics and Infertilty Research Center, Sarem Women's Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
2- Sarem gynecology, Obstetrics and Infertilty Research Center, Sarem Women's Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran. ,saremcr@gmail.com
2- Sarem gynecology, Obstetrics and Infertilty Research Center, Sarem Women's Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran. ,
Abstract: (1313 Views)
Introduction: The new coronavirus, known as Covid-19, is a highly contagious disease that is spread through the respiratory droplets of infected people. Vertical transmission is the transmission of an infectious pathogen from mother to fetus in the prenatal and postpartum period or to the infant during the postpartum period through intrauterine placenta, contact of body fluids during childbirth or through direct contact due to postpartum breastfeeding. The aim of this study was investigation of vertical transmission of the disease through mother to infant.
Material and methods: In this cross-sectional study, 117 patients participated in the study. All pregnant women had positive RT-PCR results for SARS-CoV-2 RNA. Nasopharyngeal and Oropharyngeal swabs were used to detect Covid-19 infection. To perform umbilical cord blood sampling, a sterile needle was inserted through the vagina and 10 cc of amniotic fluid was carefully inserted under sterile conditions just before rupture of the membranes and before leakage. Data were statistically analyzed using SPSS software version 24.
Results: Among the 5 cases of positive cord blood test compared to the negative cases of this test, there was no difference between the gender of the newborns (P>0.05). The average weight of babies with positive umbilical cord blood was 3067.46 grams and in babies with negative umbilical cord blood, it was 3588 grams, and a statistically significant difference was observed between these two groups (P<0.05). Also, there was no statistically significant difference between the two groups including positive and negative cord blood tests and parameters such as gender, height, weight, heart rate, breathing rate and Apgar scores of one and five minutes of newborns (P>0.05).
Conclusion: of 117 births, only 6 babies were infected with the Covid-19 virus and the height of the babies infected with this virus was lower than the babies born to healthy mothers. It is possible that the low height of the baby at birth indicates the transmission of this virus from the mother to the baby, but with this small number of infected babies, it cannot be pointed out with certainty.
Material and methods: In this cross-sectional study, 117 patients participated in the study. All pregnant women had positive RT-PCR results for SARS-CoV-2 RNA. Nasopharyngeal and Oropharyngeal swabs were used to detect Covid-19 infection. To perform umbilical cord blood sampling, a sterile needle was inserted through the vagina and 10 cc of amniotic fluid was carefully inserted under sterile conditions just before rupture of the membranes and before leakage. Data were statistically analyzed using SPSS software version 24.
Results: Among the 5 cases of positive cord blood test compared to the negative cases of this test, there was no difference between the gender of the newborns (P>0.05). The average weight of babies with positive umbilical cord blood was 3067.46 grams and in babies with negative umbilical cord blood, it was 3588 grams, and a statistically significant difference was observed between these two groups (P<0.05). Also, there was no statistically significant difference between the two groups including positive and negative cord blood tests and parameters such as gender, height, weight, heart rate, breathing rate and Apgar scores of one and five minutes of newborns (P>0.05).
Conclusion: of 117 births, only 6 babies were infected with the Covid-19 virus and the height of the babies infected with this virus was lower than the babies born to healthy mothers. It is possible that the low height of the baby at birth indicates the transmission of this virus from the mother to the baby, but with this small number of infected babies, it cannot be pointed out with certainty.
Article number: 2
Article Type: Original Research |
Subject:
Women Diseases
Received: 2022/04/17 | Accepted: 2022/06/5 | Published: 2023/01/8
Received: 2022/04/17 | Accepted: 2022/06/5 | Published: 2023/01/8
References
1. Karimi-Zarchi M, et al., Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal and pediatric pathology, 2020. 39(3): p. 246-250. [DOI:10.1080/15513815.2020.1747120]
2. Huang C, et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020. 395(10223): p. 497-506. [DOI:10.1016/S0140-6736(20)30183-5]
3. Akhigbe RE and Hamed MA, Possible links between COVID-19 and male fertility. Asian Pacific Journal of Reproduction, 2020. 9(5): p. 211-214. [DOI:10.4103/2305-0500.294662]
4. Aassve A, et al., The COVID-19 pandemic and human fertility. Science, 2020. 369(6502): p. 370-371. [DOI:10.1126/science.abc9520]
5. Rasmussen SA and Jamieson DJ, Coronavirus disease 2019 (COVID-19) and pregnancy: responding to a rapidly evolving situation. Obstetrics and gynecology, 2020. [DOI:10.1097/AOG.0000000000003873]
6. for the Prevention WG and of Neonatal C, Perinatal and neonatal management plan for prevention and control of 2019 novel coronavirus infection. Zhongguo Dang dai er ke za zhi= Chinese Journal of Contemporary Pediatrics, 2020. 22(2): p. 87-90.
7. Schwartz D and Graham A, Potential maternal and infant outcomes from (Wuhan) coronavirus SARS-CoV2 infecting pregnant women: lessons from SARS. MERS, and other human coronavirus infections, Viruses, 2020. 12(2). [DOI:10.3390/v12020194]
8. Ma K, et al., Management and clinical thinking of Coronavirus Disease 2019. Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi= Chinese journal of hepatology, 2020. 28: p. E002-E002.
9. WHO CO, World health organization. Responding to Community Spread of COVID-19. Reference WHO/COVID-19/Community_Transmission/2020.1, 2020.
10. Gorbalenya AE, et al., Severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the Coronavirus Study Group. BioRxiv, 2020. [DOI:10.1101/2020.02.07.937862]
11. Zhu Z, et al., Epidemic trend of corona virus disease 2019 (COVID-19) in mainland China. Chinese journal of preventive medicine, 2020: p. E022-E022.
12. Yang H and Duan G, Analysis on the epidemic factors for COVID-19. Zhonghua yu Fang yi xue za zhi [Chinese Journal of Preventive Medicine], 2020. 54(6): p. 608-613.
13. Berkowitz K and LaSala A, Risk factors associated with the increasing prevalence of pneumonia during pregnancy. American journal of obstetrics and gynecology, 1990. 163(3): p. 981-985. [DOI:10.1016/0002-9378(90)91109-P]
14. Bajema KL, et al., Persons evaluated for 2019 novel coronavirus-United States, January 2020. Morbidity and mortality weekly report, 2020. 69(6): p. 166.
15. Alfaraj SH, Al-Tawfiq JA, and Memish ZA, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. Journal of Microbiology, Immunology and Infection, 2019. 52: p. 501-503. [DOI:10.1016/j.jmii.2018.04.005]
16. Maxwell C, et al., No. 225-Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS). Journal of Obstetrics and Gynaecology Canada, 2017. 39(8): p. e130-e137. [DOI:10.1016/j.jogc.2017.04.024]
17. Favre G, et al., 2019-nCoV epidemic: what about pregnancies? Lancet (London, England), 2020. 395(10224): p. e40. [DOI:10.1016/S0140-6736(20)30311-1]
18. Levy A, et al., ACE2 expression and activity are enhanced during pregnancy. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008. 295(6): p. R1953-R1961. [DOI:10.1152/ajpregu.90592.2008]
19. Valdes G, et al., Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta, 2006. 27(2-3): p. 200-207. [DOI:10.1016/j.placenta.2005.02.015]
20. Kotlyar A, et al., Vertical transmission of COVID-19: a systematic review and meta-analysis. 2020.
21. Zou L, et al., SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England journal of medicine, 2020. 382(12): p. 1177-1179. [DOI:10.1056/NEJMc2001737]
22. Moreno SC, et al., Vertical transmission of COVID-19 to the neonate. Infectious diseases in obstetrics and gynecology, 2020. 2020. [DOI:10.1155/2020/8460672]
23. Chen H, et al., Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The lancet, 2020. 395(10226): p. 809-815. [DOI:10.1016/S0140-6736(20)30360-3]
24. Chen Y, et al., Infants born to mothers with a new coronavirus (COVID-19). Frontiers in pediatrics, 2020: p. 104. [DOI:10.3389/fped.2020.00104]
25. Liu Y, et al., Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J infect, 2020. 10. [DOI:10.1016/j.jinf.2020.02.028]
26. Della Gatta AN, et al., Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. American journal of obstetrics and gynecology, 2020. 223(1): p. 36-41. [DOI:10.1016/j.ajog.2020.04.013]
27. Yan J, et al., Coronavirus disease 2019 in pregnant women: a report based on 116 cases. American journal of obstetrics and gynecology, 2020. 223(1): p. 1-14. [DOI:10.1016/j.ajog.2020.04.014]
28. Rasmussen SA, et al., Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. American journal of obstetrics and gynecology, 2020. 222(5): p. 415-426. [DOI:10.1016/j.ajog.2020.02.017]
29. Xiao SY, Wu Y, and Liu H, Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring. Journal of medical virology, 2020. 92(5): p. 464. [DOI:10.1002/jmv.25702]
30. Organization WH, Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance, 17 January 2020. 2020.
31. Fang Y, et al., Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology, 2020. [DOI:10.1148/radiol.2020200432]
32. Mor G, Aldo P, and Alvero AB, The unique immunological and microbial aspects of pregnancy. Nature Reviews Immunology, 2017. 17(8): p. 469-482. [DOI:10.1038/nri.2017.64]
33. Liu H, et al., Why are pregnant women susceptible to COVID-19? An immunological viewpoint. Journal of reproductive immunology, 2020. 139: p. 103122. [DOI:10.1016/j.jri.2020.103122]
34. Kumari K, et al., Pregnancy outcomes and vertical transmission capability of SARS-CoV-2 infection among asymptomatic females: A cross-sectional study in a tertiary care rural hospital. Journal of Family Medicine and Primary Care, 2021. 10(9): p. 3247-3251. [DOI:10.4103/jfmpc.jfmpc_23_21]
35. Lei D, et al., Clinical characteristics of COVID-19 in pregnancy: analysis of nine cases. Chinese Journal of Perinatal Medicine, 2020: p. 159-165.
36. Rahnama A, et al., Possibility of Vertical Transmission of COVID-19 During Pregnancy, Labor and After Delivery: A Systematic Review Study. Disease and Diagnosis, 2022. 11(1): p. 24-30. [DOI:10.34172/ddj.2022.06]
37. Dong L, et al., Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. Jama, 2020. 323(18): p. 1846-1848. [DOI:10.1001/jama.2020.4621]
38. Lamouroux A, et al., Evidence for and against vertical transmission for severe acute respiratory syndrome coronavirus 2. American Journal of Obstetrics and Gynecology, 2020. 223(1): p. 91. e91-91. e94. [DOI:10.1016/j.ajog.2020.04.039]
39. Schwartz DA, et al., Confirming vertical fetal infection with coronavirus disease 2019: neonatal and pathology criteria for early onset and transplacental transmission of severe acute respiratory syndrome coronavirus 2 from infected pregnant mothers. Archives of pathology & laboratory medicine, 2020. 144(12): p. 1451-1456. [DOI:10.5858/arpa.2020-0442-SA]
40. Zeng L, et al., Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA pediatrics, 2020. 174(7): p. 722-725. [DOI:10.1001/jamapediatrics.2020.0878]
41. Vivanti AJ, et al., Transplacental transmission of SARS-CoV-2 infection. Nature communications, 2020. 11(1): p. 1-7. [DOI:10.1038/s41467-020-17436-6]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
